These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 18196746

  • 1. Clinical and pharmacokinetic characteristics of intracavitary administration of pegylated liposomal encapsulated doxorubicin in dogs with splenic hemangiosarcoma.
    Sorenmo K, Samluk M, Clifford C, Baez J, Barrett JS, Poppenga R, Overley B, Skorupski K, Oberthaler K, Van Winkle T, Seiler G, Shofer F.
    J Vet Intern Med; 2007; 21(6):1347-54. PubMed ID: 18196746
    [Abstract] [Full Text] [Related]

  • 2. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
    Lana S, U'ren L, Plaza S, Elmslie R, Gustafson D, Morley P, Dow S.
    J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397
    [Abstract] [Full Text] [Related]

  • 3. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
    Gardner HL, London CA, Portela RA, Nguyen S, Rosenberg MP, Klein MK, Clifford C, Thamm DH, Vail DM, Bergman P, Crawford-Jakubiak M, Henry C, Locke J, Garrett LD.
    BMC Vet Res; 2015 Jun 11; 11():131. PubMed ID: 26062540
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
    U'Ren LW, Biller BJ, Elmslie RE, Thamm DH, Dow SW.
    J Vet Intern Med; 2007 Jun 11; 21(1):113-20. PubMed ID: 17338158
    [Abstract] [Full Text] [Related]

  • 5. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.
    Vail DM, MacEwen EG, Kurzman ID, Dubielzig RR, Helfand SC, Kisseberth WC, London CA, Obradovich JE, Madewell BR, Rodriguez CO.
    Clin Cancer Res; 1995 Oct 11; 1(10):1165-70. PubMed ID: 9815908
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma.
    Sorenmo KU, Baez JL, Clifford CA, Mauldin E, Overley B, Skorupski K, Bachman R, Samluk M, Shofer F.
    J Vet Intern Med; 2004 Oct 11; 18(2):209-13. PubMed ID: 15058772
    [Abstract] [Full Text] [Related]

  • 9. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study.
    Kahn SA, Mullin CM, de Lorimier LP, Burgess KE, Risbon RE, Fred RM, Drobatz K, Clifford CA.
    Can Vet J; 2013 Mar 11; 54(3):237-42. PubMed ID: 23997259
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of the anti-tumour activity of Coriolus versicolor polysaccharopeptide (I'm-Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma.
    Gedney A, Salah P, Mahoney JA, Krick E, Martins R, Scavello H, Lenz JA, Atherton MJ.
    Vet Comp Oncol; 2022 Sep 11; 20(3):688-696. PubMed ID: 35442554
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma.
    Musser ML, Coto GM, Lingnan Y, Mochel JP, Johannes CM.
    PLoS One; 2022 Sep 11; 17(12):e0279594. PubMed ID: 36548371
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma.
    Adachi M, Hoshino Y, Izumi Y, Takagi S.
    J Vet Med Sci; 2016 May 03; 78(4):649-56. PubMed ID: 26685984
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology.
    Marconato L, Chalfon C, Finotello R, Polton G, Vasconi ME, Annoni M, Stefanello D, Mesto P, Capitani O, Agnoli C, Amati M, Sabattini S.
    Vet Comp Oncol; 2019 Dec 03; 17(4):537-544. PubMed ID: 31251441
    [Abstract] [Full Text] [Related]

  • 17. Treatment of canine hemangiosarcoma: 2000 and beyond.
    Clifford CA, Mackin AJ, Henry CJ.
    J Vet Intern Med; 2000 Dec 03; 14(5):479-85. PubMed ID: 11012108
    [Abstract] [Full Text] [Related]

  • 18. Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: a progress review.
    MacEwen EG, Kurzman ID, Helfand S, Vail D, London C, Kisseberth W, Rosenthal RC, Fox LE, Keller ET, Obradovich J.
    J Drug Target; 1994 Dec 03; 2(5):391-6. PubMed ID: 7704483
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma.
    Hammer AS, Couto CG, Filppi J, Getzy D, Shank K.
    J Vet Intern Med; 1991 Dec 03; 5(3):160-6. PubMed ID: 1920253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.